A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice.

Autor: Onishi, Tomohiro1 tomohiro.onishi@takeda.com, Maeda, Ryouta1, Terada, Michiko1, Sato, Sho2, Fujii, Takahiro1, Ito, Masahiro1, Hashikami, Kentaro3, Kawamoto, Tomohiro3, Tanaka, Maiko1
Zdroj: Scientific Reports. 7/29/2021, Vol. 11 Issue 1, p1-11. 11p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje